Plexus Corp. (NASDAQ:PLXS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Plexus Corp. (NASDAQ:PLXSGet Rating) has been assigned a consensus recommendation of “Hold” from the six brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have given a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $107.00.

A number of equities analysts have commented on PLXS shares. Needham & Company LLC decreased their price target on Plexus from $112.00 to $108.00 and set a “buy” rating on the stock in a research note on Friday, January 27th. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $116.00 price objective for the company in a research note on Friday, January 27th. JPMorgan Chase & Co. reduced their price target on Plexus from $90.00 to $86.00 and set an “underweight” rating on the stock in a report on Friday, January 27th. Finally, StockNews.com assumed coverage on shares of Plexus in a research report on Thursday, May 18th. They issued a “hold” rating for the company.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $87.20 on Tuesday. The company has a market capitalization of $2.41 billion, a PE ratio of 14.41 and a beta of 1.11. The company has a quick ratio of 0.59, a current ratio of 1.45 and a debt-to-equity ratio of 0.16. The stock’s 50 day moving average price is $91.47 and its 200-day moving average price is $99.39. Plexus has a twelve month low of $74.53 and a twelve month high of $115.36.

Plexus (NASDAQ:PLXSGet Rating) last posted its quarterly earnings data on Wednesday, April 26th. The technology company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.29. The business had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.04 billion. Plexus had a return on equity of 15.24% and a net margin of 4.00%. The business’s revenue was up 20.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.95 earnings per share. On average, equities analysts anticipate that Plexus will post 5.48 EPS for the current year.

Insiders Place Their Bets

In other Plexus news, EVP Ronnie Darroch sold 4,424 shares of the firm’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $89.12, for a total transaction of $394,266.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.05% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Credit Agricole S A acquired a new position in shares of Plexus during the 3rd quarter valued at $25,000. CWM LLC increased its stake in shares of Plexus by 42.4% in the 1st quarter. CWM LLC now owns 413 shares of the technology company’s stock valued at $40,000 after acquiring an additional 123 shares during the last quarter. Ronald Blue Trust Inc. raised its stake in shares of Plexus by 86.9% in the 4th quarter. Ronald Blue Trust Inc. now owns 815 shares of the technology company’s stock valued at $71,000 after purchasing an additional 379 shares during the period. Tower Research Capital LLC TRC raised its stake in Plexus by 680.8% in the first quarter. Tower Research Capital LLC TRC now owns 773 shares of the technology company’s stock valued at $75,000 after buying an additional 674 shares during the period. Finally, UBS Group AG raised its stake in Plexus by 294.9% in the third quarter. UBS Group AG now owns 924 shares of the technology company’s stock valued at $81,000 after purchasing an additional 690 shares in the last quarter. 96.01% of the stock is owned by hedge funds and other institutional investors.

Plexus Company Profile

(Get Rating)

Plexus Corp. engages in the provision of electronic manufacturing services. The firm partners with companies to transform concepts into branded products and deliver them to the market. It has partnerships with customers in the healthcare and life sciences, industrial and commercial, communications, and aerospace and defense market sectors.

Read More

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.